Analysis of The Clinical Application of Human Serum Albumin in Tumor Patients of Our Hospital
10.6039/j.issn.1001-0408.2015.20.02
- VernacularTitle:我院肿瘤患者人血白蛋白临床应用分析Δ
- Author:
Juan DU
;
Xiuli ZHAO
;
Lin LIU
- Publication Type:Journal Article
- Keywords:
Tumor;
Human serum albumin;
Rational drug use
- From:
China Pharmacy
2015;(20):2739-2741
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide references for rational clinical application of human serum albumin. METHODS:By adopting retrospective analysis,medical records of 256 tumor inpatients administered with human serum albumin in the affiliated cancer hospital of zhengzhou university during Jan. and Jun. 2014 were randomly selected to statistically analyze the drug consump-tion amount per capita,average course of treatment and the concentration of serum albumin in the patient before administration. RE-SULTS:In our hospital,human serum albumin was used in 15 clinical departments,mainly in non-surgical departments. The pa-tients received drugs at a single dose ranging from 10 to 20 g. Postoperative patients with hypoalbuminemia topped the list in terms of daily consumption amount of human serum albumin(15.82 g/d)and patients with hypoalbuminemia accompanied by ascites and pleural effusion experienced the longest average course of treatment(6.93 d). Human serum albumin was mainly used for hypopro-teinemia. CONCLUSIONS:The use of human serum albumin in our hospital conformed to the dispensatory and the regulations on the medical insurance organizations of Henan Province. However,it is not in compliance with the regulations on the medical insur-ance organizations of Beijing and the guidelines of the hospital associations of American universities. Therefore,the indication of human serum albumin needs to be further defined,and priority should be given to nutrition supply for the inpatient with hypoalbu-minemia caused by malnutrition.
